Kala Bio (KALA) Invested Capital (2016 - 2025)

Kala Bio has reported Invested Capital for 7 years, with the latest figure at $28.4 million in Q3 2025.

• Quarterly Invested Capital rose 58.04% year-over-year to $28.4 million in Q3 2025, while the trailing twelve-month figure through Mar 2026 was $37.9 million (down 32.04% YoY) and the FY2024 annual result came in at $10.3 million, changed N/A from the prior year.
• Invested Capital improved to $28.4 million in Q3 2025 per KALA's latest filing, from $9.5 million in the prior quarter.
• Over five years, Invested Capital peaked at $28.4 million in Q3 2025 and troughed at $3.7 million in Q1 2022.
• A 4-year average of $9.9 million and a median of $7.8 million in 2024 frame the typical range for Invested Capital.
• The widest YoY moves for Invested Capital: up 158.73% in 2025, down 20.64% in 2025.
• Over 4 years, Invested Capital stood at $3.8 million in 2021, then rose by 8.62% to $4.1 million in 2022, then jumped by 149.3% to $10.3 million in 2024, then surged by 174.87% to $28.4 million in 2025.
• According to Business Quant data, Invested Capital over the past three periods registered $28.4 million, $9.5 million, and $15.5 million for Q3 2025, Q2 2025, and Q1 2025 respectively.